GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 34,537.1 million compared to INR 32,517.2 million a year ago. Revenue was INR 35,763 million compared to INR 33,523.8 million a year ago.

Net income was INR 5,899.6 million compared to INR 6,106.9 million a year ago. Basic earnings per share from continuing operations was INR 34.83 compared to INR 35.87 a year ago. Diluted earnings per share from continuing operations was INR 34.83 compared to INR 35.87 a year ago.

Basic earnings per share was INR 34.83 compared to INR 36.05 a year ago. Diluted earnings per share was INR 34.83 compared to INR 36.05 a year ago.